We and our present 52,000 shares agree, cheynew, even tough those shares are currently profitable at overall entry points of $6.22 and $2.41 in taxable and SEP-IRA accounts.
Dew Diligence has an interesting post on the Biotech Value board yesterday that Roche and LLY are openly opposing NVO's purchase of 3 sites of Catalent that can do what CDMO can do with its single use reactors. About 76% of NVO's authorized shares are held by a holding company located in Europe-- Denmark or the Netherlands I recall from this past Sunday's CBS-TV program "60 Minutes." NVO and its holding company together comprise one of the largest companies in the world in market value. CNBC-TV will interview NVO's CEO today in 11:00-12:00 time frame.
How long do you think Avid will remain privately held? Would HALO and/or JNJ bid higher for CDMO? How about VKTX that is actively seeking a site to produce its weight-loss drugs?
Market Data 
Markets 
AI
